In vitro lung deposition of fluticasone propionate/formoterol (FP/FORM) pressurized metered dose inhaler (pMDI) with different inhalation profiles

被引：0

作者：

Van Holsbeke, Cedric

Marshall, Jonathan

De Backer, Jan

Vos, Wim

机构：

来源：

EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷

关键词：

Asthma; -; management; Imaging; Treatments;

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：4

共 50 条

[1] IN VITRO LUNG DEPOSITION OF FLUTICASONE PROPIONATE/FORMOTEROL (FP/FORM) PRESSURIZED METERED DOSE INHALER (PMDI) WITH DIFFERENT INHALATION PROFILES
Van Holsbeke, C.
Marshall, J.
De Backer, J.
Vos, W.
RESPIROLOGY, 2014, 19 : 70 - 70
[2] Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma
Dunlop, William
Heron, Louise
Fox, Georgia
Greaney, Maire
ADVANCES IN THERAPY, 2013, 30 (10) : 933 - 944
[3] Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma
William Dunlop
Louise Heron
Georgia Fox
Maire Greaney
Advances in Therapy, 2013, 30 : 933 - 944
[4] The effect of inhalation duration on lung deposition with a pressurized metered-dose inhaler (pMDI)
Van Holsbeke, Cedric
Marshall, Jonathan
De Backer, Jan
Vos, Wim
EUROPEAN RESPIRATORY JOURNAL, 2014, 44
[5] THE EFFECT OF INHALATION DURATION ON LUNG DEPOSITION WITH A PRESSURIZED METERED-DOSE INHALER (PMDI)
Van Holsbeke, C.
Marshall, J.
De Backer, J.
Vos, W.
RESPIROLOGY, 2014, 19 : 64 - 64
[6] Relative pulmonary bioavailability (BA) of fluticasone propionate/formoterol (FP/FORM) via pressurised metered-dose inhaler (pMDI) and a novel breath-triggered inhaler (BTI)
Bell, David
Mundin, Gill
Lomax, Mark
Woodward, Jo
Dissanayake, Sanjeeva
Overend, Tim
EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[7] PATIENT HANDLING STUDY OF FLUTICASONE PROPIONATE/FORMOTEROL FUMARATE PRESSURIZED METERED-DOSE INHALER
Bell, D.
Mansfield, L.
Lomax, M.
Dissanayake, S.
RESPIROLOGY, 2014, 19 : 6 - 6
[8] Systemic bioavailability (BA) and pharmacodynamics (PD) of fluticasone propionate/formoterol (FP/FORM) via pressurised metered-dose inhaler (pMDI) or a novel breath-triggered inhaler (BTI)
Bell, David
Mundin, Gill
Lomax, Mark
Woodward, Jo
Dalvi, Prashant
Dissanayake, Sanjeeva
EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[9] Effect of Fluticasone/Formoterol Pressurized Metered-Dose Inhaler (pMDI) in Early Management of Acute Exacerbations of Asthma
Agarwal, S. K.
Sharma, S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
[10] Early bronchodilatory effects of Budesonide/Formoterol pressurized metered-dose inhaler (pMDI) compared with fluticasone Propionate/Salmeterol dry powder inhaler (DPI) and albuterol pMDI in adults with asthma
Hampel, F. C., Jr.
Martin, P.
Mezzanotte, W. S.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S220 - S221

← 1 2 3 4 5 →